Luis Jhordy Alfaro Quillas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Luis Jhordy Alfaro Quillas has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Edson Moleta Colodel
Universidade Federal de Mato Grosso, Brazil
2 shared publications - Javier Enciso
Regenerative Medicine Group , Scientific University of the South , Lima , Peru
2 shared publications - Nathaly Enciso
Regenerative Medicine Group , Scientific University of the South , Lima , Peru
2 shared publications - Alcyjara Rêgo Costa
Universidade Estadual do Maranhão
1 shared publication - Alexandre Pinto Ribeiro
Universidade Federal de Mato Grosso
1 shared publication Ana Paula Carneiro dos Santos
1 shared publication
Latest Publications
- Open Access
- 19 November 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Squamous cell carcinoma involving the uropygial gland region in related captive budgerigars: a clinicopathological case series
Squamous cell carcinoma (SCC) involving the uropygial gland region is an uncommon epithelial malignancy in birds, and detailed descriptions in budgerigars remain limited. This study describes uropygial gland region lesions in six full-sibling captive budgerigars maintained under the same husbandry conditions. All birds had proliferative, nodular, verrucous, ulcerated or exudative lesions in the uropygial gland region. Fine-needle aspiration cytology was performed in all six birds and supported an epithelial neoplasm, showing atypical epithelial cells with anisocytosis, anisokaryosis, perinuclear vacuolation, atypical keratinization and mitotic figures. Radiographs obtained from four birds showed soft-tissue opacities in the dorsocaudal body region, consistent with enlargement of the uropygial gland region, without detectable mineralisation or bone involvement. SCC was histologically confirmed in five sampled birds, including one necropsied bird and four surgically excised lesions; one additional bird had compatible clinical and cytological findings but died before tissue sampling. Histology revealed infiltrative, non-encapsulated neoplasms composed of pleomorphic squamous epithelial cells forming keratin pearls and invading adjacent dermis and skeletal muscles. Cytokeratin AE1/AE3 immunolabeling supported epithelial differentiation. Three surgically treated birds were followed for up to eight months without owner-reported or clinically detected local recurrence. These findings highlight the value of integrating clinical examination, cytology, imaging, histopathology and immunohistochemistry for diagnosing SCC involving the uropygial gland region in budgerigars.
- 19 November 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessSquamous cell carcinoma involving the uropygial gland region in related captive budgerigars: a clinicopathological case series
Squamous cell carcinoma (SCC) involving the uropygial gland region is an uncommon epithelial malignancy in birds, and detailed descriptions in budgerigars remain limited. This study describes uropygial gland region lesions in six full-sibling captive budgerigars maintained under the same husbandry conditions. All birds had proliferative, nodular, verrucous, ulcerated or exudative lesions in the uropygial gland region. Fine-needle aspiration cytology was performed in all six birds and supported an epithelial neoplasm, showing atypical epithelial cells with anisocytosis, anisokaryosis, perinuclear vacuolation, atypical keratinization and mitotic figures. Radiographs obtained from four birds showed soft-tissue opacities in the dorsocaudal body region, consistent with enlargement of the uropygial gland region, without detectable mineralisation or bone involvement. SCC was histologically confirmed in five sampled birds, including one necropsied bird and four surgically excised lesions; one additional bird had compatible clinical and cytological findings but died before tissue sampling. Histology revealed infiltrative, non-encapsulated neoplasms composed of pleomorphic squamous epithelial cells forming keratin pearls and invading adjacent dermis and skeletal muscles. Cytokeratin AE1/AE3 immunolabeling supported epithelial differentiation. Three surgically treated birds were followed for up to eight months without owner-reported or clinically detected local recurrence. These findings highlight the value of integrating clinical examination, cytology, imaging, histopathology and immunohistochemistry for diagnosing SCC involving the uropygial gland region in budgerigars.
- Open Access
- 25 August 2026
- Published by Elsevier in International Journal for Parasitology: Parasites and Wildlife
- Vol. 31
Pathological and morphometric characterization of intestinal lesions associated with natural infection by Oligacanthorhynchus microcephalus in white-eared opossums (Didelphis albiventris)
- 25 August 2026
- Published by Elsevier in International Journal for Parasitology: Parasites and Wildlife
- Vol. 31
Open AccessPathological and morphometric characterization of intestinal lesions associated with natural infection by Oligacanthorhynchus microcephalus in white-eared opossums (Didelphis albiventris)
- 11 August 2026
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 229, 35-38
Giant paraovarian cyst causing abdominal distention in a Swiss mouse (Mus musculus)
- 11 August 2026
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 229, 35-38
Giant paraovarian cyst causing abdominal distention in a Swiss mouse (Mus musculus)
- Open Access
- 25 January 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (1) , 295-309
Conjunctival transforming growth factor-β2 and vascular endothelial growth factor in canine keratoconjunctivitis sicca: Baseline alterations, clinical associations, and response to 0.2% cyclosporine therapy
Background and Aim: Transforming growth factor-β2 (TGF-β2) and vascular endothelial growth factor (VEGF) are key mediators of inflammation, fibrosis, and angiogenesis in ocular surface disease. However, their roles in canine keratoconjunctivitis sicca (KCS) are not well understood. This study aimed to compare conjunctival TGF-β2 and VEGF levels between healthy dogs and those with KCS, evaluate the effects of 6-week therapy with 0.2% cyclosporine A (CsA), and explore associations with clinical signs, Schirmer tear test-1 (STT-1), goblet cell density (GCD), and inflammatory cell infiltration. Materials and Methods: Thirty-three dogs with KCS, classified as mild (n = 10), moderate (n = 10), or severe (n = 13), underwent ophthalmic exams, STT-1 measurements, and conjunctival biopsies before treatment (T0) and after 6 weeks of topical CsA therapy (T1). Fourteen healthy dogs served as controls. Conjunctival samples were analyzed for GCD, inflammatory cell counts, and TGF-β2 and VEGF levels using histology and enzyme-Linked Immunosorbent Assay. Clinical scoring and corneal vascular quantification were performed using standardized protocols. Statistical comparisons were made within and between groups, as well as through correlation analyses. Results: CsA significantly increased STT-1 in all KCS grades and improved selected clinical signs. GCD in KCS dogs increased at T1, reaching levels comparable to controls, although not statistically significant. Neutrophils were the only inflammatory cells to significantly decrease after treatment. Overall, TGF-β2 levels did not differ between controls and KCS dogs; however, concentrations increased with disease severity and showed a positive correlation with lymphocyte counts and corneal melanosis, and a negative correlation with GCD. VEGF levels were mildly elevated in KCS but decreased significantly following CsA treatment, especially in severe cases, and correlated positively with corneal melanosis and negatively with corneal vessel counts. A positive correlation was observed between TGF-β2 and VEGF. Conclusion: Topical 0.2% CsA improves tear production, GCD restoration, and various clinical signs in canine KCS. TGF-β2 seems to have a pro-inflammatory and profibrotic role, increasing with disease severity and linked to chronic ocular surface changes. CsA effectively decreases VEGF, especially in severe KCS, indicating partial modulation of angiogenic pathways. Longer treatment durations may be necessary to influence TGF-β2-mediated tissue remodeling. Keywords: canine keratoconjunctivitis sicca, cyclosporine therapy, goblet cell density, ocular surface inflammation, tear film biomarkers, transforming growth factor-β2, vascular endothelial growth factor, veterinary ophthalmology.
- 25 January 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (1) , 295-309
Open AccessConjunctival transforming growth factor-β2 and vascular endothelial growth factor in canine keratoconjunctivitis sicca: Baseline alterations, clinical associations, and response to 0.2% cyclosporine therapy
Background and Aim: Transforming growth factor-β2 (TGF-β2) and vascular endothelial growth factor (VEGF) are key mediators of inflammation, fibrosis, and angiogenesis in ocular surface disease. However, their roles in canine keratoconjunctivitis sicca (KCS) are not well understood. This study aimed to compare conjunctival TGF-β2 and VEGF levels between healthy dogs and those with KCS, evaluate the effects of 6-week therapy with 0.2% cyclosporine A (CsA), and explore associations with clinical signs, Schirmer tear test-1 (STT-1), goblet cell density (GCD), and inflammatory cell infiltration. Materials and Methods: Thirty-three dogs with KCS, classified as mild (n = 10), moderate (n = 10), or severe (n = 13), underwent ophthalmic exams, STT-1 measurements, and conjunctival biopsies before treatment (T0) and after 6 weeks of topical CsA therapy (T1). Fourteen healthy dogs served as controls. Conjunctival samples were analyzed for GCD, inflammatory cell counts, and TGF-β2 and VEGF levels using histology and enzyme-Linked Immunosorbent Assay. Clinical scoring and corneal vascular quantification were performed using standardized protocols. Statistical comparisons were made within and between groups, as well as through correlation analyses. Results: CsA significantly increased STT-1 in all KCS grades and improved selected clinical signs. GCD in KCS dogs increased at T1, reaching levels comparable to controls, although not statistically significant. Neutrophils were the only inflammatory cells to significantly decrease after treatment. Overall, TGF-β2 levels did not differ between controls and KCS dogs; however, concentrations increased with disease severity and showed a positive correlation with lymphocyte counts and corneal melanosis, and a negative correlation with GCD. VEGF levels were mildly elevated in KCS but decreased significantly following CsA treatment, especially in severe cases, and correlated positively with corneal melanosis and negatively with corneal vessel counts. A positive correlation was observed between TGF-β2 and VEGF. Conclusion: Topical 0.2% CsA improves tear production, GCD restoration, and various clinical signs in canine KCS. TGF-β2 seems to have a pro-inflammatory and profibrotic role, increasing with disease severity and linked to chronic ocular surface changes. CsA effectively decreases VEGF, especially in severe KCS, indicating partial modulation of angiogenic pathways. Longer treatment durations may be necessary to influence TGF-β2-mediated tissue remodeling. Keywords: canine keratoconjunctivitis sicca, cyclosporine therapy, goblet cell density, ocular surface inflammation, tear film biomarkers, transforming growth factor-β2, vascular endothelial growth factor, veterinary ophthalmology.
- Open Access
- 1 January 2026
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2026 (1) , 3265988
Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours
Introduction: There is no specific therapy for triple‐negative breast cancer (TNBC), and the recurrence rate is high. Cancer stem cells (CSCs) play an important role in cancer chemoresistance and metastasis, but there is no consensus marker in this type of cancer. The aim of this study was to identify CSC biomarkers in the plasma secretome of TNBC patients. Methods: CD44+/CD24− CSCs were isolated from MDA‐MB‐436 and MDA‐MB‐231 (ATCC) lines by magnetic immunoselection. The extracellular vesicles (EVs) of CSCs were isolated by size exclusion chromatography (SEC) of conditioned medium (CM) without fetal bovine serum (FBS) and blood plasma from TNBC and healthy women. Tetraspanins CD9 and CD81 identified the EVs, while electron microscopy determined the morphology and tunable resistive pulse sensing (TRPS) established particle size. Luminex technology was used to determine the presence of L1 cell adhesion molecule (L1CAM), carbonic anhydrase IX (CA9), mesothelin, midkine, hepsin, kallikrein‐6 (KLK6), transglutaminase 2 (TGM2), aldehyde dehydrogenase 1a1 (ALDH1A1), epithelial cell adhesion molecule (EpCAM), and differentiation cluster 44 (CD44). Results: Particles of 0–200 nm in size were more frequent in CSC‐MDA‐MB‐436, while particles of 201–500 nm were more frequent in CSC‐MDA‐MB‐231. In blood plasma, the particle size was 150–250 nm in TNBC patients and 150–300 nm in healthy individuals. Particle concentrations were 1.3 × 10 10 in CSCs of the MDA‐MB‐231 (CSC‐MDA‐MB‐231) cell line and 3.8 × 10 7 in the MDA‐MB‐231 cell line (L‐MDA‐MB‐231). The concentration of CSCs in MDA‐MB‐436 was 2.7 × 10 8 compared to 9.4 × 10 7 in L‐MDA‐MB‐436. Midkine and CA9 were present in the EVs of both CSC lines and in the plasma of women with TNBC but absent in the blood plasma of healthy women. Midkine showed better statistical discrimination. Conclusions: The size and concentration of EVs are heterogeneous. Midkine and CA9 are produced by CSCs in women with TNBC and may be possible biomarkers of these cells in this tumour type.
- 1 January 2026
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2026 (1) , 3265988
Open AccessMidkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours
Introduction: There is no specific therapy for triple‐negative breast cancer (TNBC), and the recurrence rate is high. Cancer stem cells (CSCs) play an important role in cancer chemoresistance and metastasis, but there is no consensus marker in this type of cancer. The aim of this study was to identify CSC biomarkers in the plasma secretome of TNBC patients. Methods: CD44+/CD24− CSCs were isolated from MDA‐MB‐436 and MDA‐MB‐231 (ATCC) lines by magnetic immunoselection. The extracellular vesicles (EVs) of CSCs were isolated by size exclusion chromatography (SEC) of conditioned medium (CM) without fetal bovine serum (FBS) and blood plasma from TNBC and healthy women. Tetraspanins CD9 and CD81 identified the EVs, while electron microscopy determined the morphology and tunable resistive pulse sensing (TRPS) established particle size. Luminex technology was used to determine the presence of L1 cell adhesion molecule (L1CAM), carbonic anhydrase IX (CA9), mesothelin, midkine, hepsin, kallikrein‐6 (KLK6), transglutaminase 2 (TGM2), aldehyde dehydrogenase 1a1 (ALDH1A1), epithelial cell adhesion molecule (EpCAM), and differentiation cluster 44 (CD44). Results: Particles of 0–200 nm in size were more frequent in CSC‐MDA‐MB‐436, while particles of 201–500 nm were more frequent in CSC‐MDA‐MB‐231. In blood plasma, the particle size was 150–250 nm in TNBC patients and 150–300 nm in healthy individuals. Particle concentrations were 1.3 × 10 10 in CSCs of the MDA‐MB‐231 (CSC‐MDA‐MB‐231) cell line and 3.8 × 10 7 in the MDA‐MB‐231 cell line (L‐MDA‐MB‐231). The concentration of CSCs in MDA‐MB‐436 was 2.7 × 10 8 compared to 9.4 × 10 7 in L‐MDA‐MB‐436. Midkine and CA9 were present in the EVs of both CSC lines and in the plasma of women with TNBC but absent in the blood plasma of healthy women. Midkine showed better statistical discrimination. Conclusions: The size and concentration of EVs are heterogeneous. Midkine and CA9 are produced by CSCs in women with TNBC and may be possible biomarkers of these cells in this tumour type.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1)
Severe Fibrosing Pleuritis Secondary to Chronic Chylothorax in a Domestic Cat
Fibrosing pleuritis is a serious respiratory complication associated with chronic inflammation of the pleura, which leads to pleural thickening, atelectasis, or pulmonary entrapment, and an unfavorable prognosis. In cats, it is rare and is mainly caused by chylothorax—an effusion that is particularly irritating to the thoracic cavity. Chylous pleural effusions may occur secondary to disease or be idiopathic. This report describes the clinical presentation, laboratory, imaging, and histopathological findings of a case of severe fibrosing pleuritis secondary to chronic chylothorax in a domestic cat. A 3‐year‐old female mixed‐breed cat was treated at the Veterinary Hospital of the Federal University of Mato Grosso, complaining of tachypnea, dyspnea, appetite loss, lethargy, and nausea. Imaging revealed marked bilateral pleural effusion with pulmonary atelectasis, and the pleural fluid was classified as a modified chylous effusion. The cat presented recurrence and unfavorable progression of the condition over a period of 34 months and died. At necropsy, severe fibrosing pleuritis, reduced lung volume, and pulmonary fibrosis were evidenced. Due to the poor prognosis, it is essential to identify the underlying disease early to intervene and prevent the development of pleural fibrosis.
- 1 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1)
Open AccessSevere Fibrosing Pleuritis Secondary to Chronic Chylothorax in a Domestic Cat
Fibrosing pleuritis is a serious respiratory complication associated with chronic inflammation of the pleura, which leads to pleural thickening, atelectasis, or pulmonary entrapment, and an unfavorable prognosis. In cats, it is rare and is mainly caused by chylothorax—an effusion that is particularly irritating to the thoracic cavity. Chylous pleural effusions may occur secondary to disease or be idiopathic. This report describes the clinical presentation, laboratory, imaging, and histopathological findings of a case of severe fibrosing pleuritis secondary to chronic chylothorax in a domestic cat. A 3‐year‐old female mixed‐breed cat was treated at the Veterinary Hospital of the Federal University of Mato Grosso, complaining of tachypnea, dyspnea, appetite loss, lethargy, and nausea. Imaging revealed marked bilateral pleural effusion with pulmonary atelectasis, and the pleural fluid was classified as a modified chylous effusion. The cat presented recurrence and unfavorable progression of the condition over a period of 34 months and died. At necropsy, severe fibrosing pleuritis, reduced lung volume, and pulmonary fibrosis were evidenced. Due to the poor prognosis, it is essential to identify the underlying disease early to intervene and prevent the development of pleural fibrosis.
- Open Access
- 1 September 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in International Journal of Morphology
- Vol. 36 (3) , 792-798
Ultraestructura del Inmunofenotipo CD44+/CD24- de una Línea de Células de Cáncer de Mama Triple Negativo
El cáncer de mama es la principal causa de muerte debido al cáncer en mujeres. La microscopía electrónica permite establecer características constitutivas de las células entre diferentes poblaciones celulares. Las células madre del cáncer mamario con inmunofenotipo CD44alta/CD24baja son una población de células intratumorales asociada a la quimioresistencia y metástasis, cuya ultraestructura aún no ha sido bien estudiada. El objetivo de este trabajo fue conocer características ultraestructurales de células con fenotipo de células madre del cáncer de la línea celular MDA-MB-436 de tumor mamario triple negativo comparándolas con células madre adiposas. Se utilizó microscopía electrónica de barrido y de transmisión. Previamente, mediante separación inmunomagnética positiva empleando anticuerpos anti CD44 y anti CD24 unidos a perlas magnéticas, se obtuvo una población de células con fenotipo CD44alta/CD24baja a partir de 10x106 células de la línea MDA-MB-436, la cual igual que las células madre adiposas fue cultivada en cubreobjetos para microscopía electrónica de barrido; en tanto que para microscopía electrónica de transmisión se obtuvo un pellet de células, luego se fijó con glutaraldehído al 2,5 % y post fijó con OsO4 1 %. Para microscopía óptica de alta resolución se usó azul de toluidina como tinción. Luego de obtener el fenotipo de células madre del cáncer se corroboró su pluripotencia detectando la expresión de los genes Oct4 y nanog mediante RT-PCR. Nuestros resultados muestran que las células de este fenotipo son pequeñas, redondeadas, recubiertas por microvellosidades abundantes pero cortas; el citoplasma tiene organelas de secreción celular y abundantes mitocondrias alargadas; el núcleo es excéntrico ocupando la mitad del volumen celular, el nucléolo es voluminoso y la heterocromatina está adosada a la membrana nuclear interna. Se concluye que el inmunofenotipo celular estudiado es una sub población celular dentro de la línea estudiada que difiere en tamaño y ultraestructura de las células madre adiposas.
- 1 September 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in International Journal of Morphology
- Vol. 36 (3) , 792-798
Open AccessUltraestructura del Inmunofenotipo CD44+/CD24- de una Línea de Células de Cáncer de Mama Triple Negativo
El cáncer de mama es la principal causa de muerte debido al cáncer en mujeres. La microscopía electrónica permite establecer características constitutivas de las células entre diferentes poblaciones celulares. Las células madre del cáncer mamario con inmunofenotipo CD44alta/CD24baja son una población de células intratumorales asociada a la quimioresistencia y metástasis, cuya ultraestructura aún no ha sido bien estudiada. El objetivo de este trabajo fue conocer características ultraestructurales de células con fenotipo de células madre del cáncer de la línea celular MDA-MB-436 de tumor mamario triple negativo comparándolas con células madre adiposas. Se utilizó microscopía electrónica de barrido y de transmisión. Previamente, mediante separación inmunomagnética positiva empleando anticuerpos anti CD44 y anti CD24 unidos a perlas magnéticas, se obtuvo una población de células con fenotipo CD44alta/CD24baja a partir de 10x106 células de la línea MDA-MB-436, la cual igual que las células madre adiposas fue cultivada en cubreobjetos para microscopía electrónica de barrido; en tanto que para microscopía electrónica de transmisión se obtuvo un pellet de células, luego se fijó con glutaraldehído al 2,5 % y post fijó con OsO4 1 %. Para microscopía óptica de alta resolución se usó azul de toluidina como tinción. Luego de obtener el fenotipo de células madre del cáncer se corroboró su pluripotencia detectando la expresión de los genes Oct4 y nanog mediante RT-PCR. Nuestros resultados muestran que las células de este fenotipo son pequeñas, redondeadas, recubiertas por microvellosidades abundantes pero cortas; el citoplasma tiene organelas de secreción celular y abundantes mitocondrias alargadas; el núcleo es excéntrico ocupando la mitad del volumen celular, el nucléolo es voluminoso y la heterocromatina está adosada a la membrana nuclear interna. Se concluye que el inmunofenotipo celular estudiado es una sub población celular dentro de la línea estudiada que difiere en tamaño y ultraestructura de las células madre adiposas.